|
Getting your Trinity Audio player ready...
|
Synergy CHC Corp. (NASDAQ: SNYR), a consumer health and wellness company, has reported its financial results for Q2 2025, marking its tenth consecutive quarter of profitability. The company posted revenue of $8.1 million, gross margin of 76.7%, and net income of $1.5 million—up 125% year-over-year—with earnings per share rising 86% to $0.17. EBITDA surged 136% to $3.8 million. See Entire Press Release.
In addition to Synergy CHC Corp. (NASDAQ: SNYR) keep an eye on these Mag 7 Undercard Stocks: Expion360 Inc. (NASDAQ: XPON), Biomerica Inc. (NASDAQ: BMRA), Opendoor Technologies (NASDAQ: OPEN), Trinity Biotech plc (NASDAQ: TRIB), Aeries Technology Inc. (NASDAQ: AERT), Power Metallic Inc. (OTCQB: PNPNF | TSX.V: PNPN), Inspire Veterinary Inc. (NASDAQ: IVP)as they are moving aggressively in early trading today.
CEO Jack Ross credited disciplined execution and strategic growth initiatives for the results, highlighting the expansion of FOCUSfactor into Turkey, UAE, etc. via a licensing agreement and strong momentum in the ready-to-drink beverage line, supported by new leadership and North American distribution partnerships. Synergy also completed a $20 million debt refinancing, extending maturity to 2029 and enhancing financial flexibility.
Focusfactor® a 25-year legacy product, already boasts established US Canadian and UK distribution via Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), CVS (NYSE: CVS), and Walgreens (NASDAQ: WBA) among others — continues and is further penetrating growth acceleration into new markets. Plus key retail wins across mass, grocery, pharmacy, convenience, and wholesale channels are set to drive meaningful gains in late 2025. Internationally, the company’s licensing deals now cover both the UAE and Turkey. With a strengthened balance sheet, working capital surplus of $12.4 million, and ongoing brand growth, Synergy says it is well positioned to accelerate in the second half of 2025 and beyond.